Modelled DT Structure
Method: multi-sequence alignment based machine learning
Detail: Structure Info
General Information of DT | |||||
---|---|---|---|---|---|
DT ID | DTD0243 | ||||
Gene Name | SLC27A6 | ||||
Protein Name | Long-chain fatty acid transport protein 6 | ||||
Gene ID | |||||
UniProt ID | |||||
TCDB ID | |||||
3D Structure |
Modelled DT Structure Method: multi-sequence alignment based machine learning Detail: Structure Info |
||||
Synonyms | ACSVL2; FACVL2; FATP-6; FATP6; Fatty acid transport protein 6; Fatty-acid-coenzyme A ligase, very long-chain 2; SLC27A6; Solute carrier family 27 member 6; VLCS-H1; VLCSH1; Very long-chain acyl-CoA synthetase homolog 1; hVLCS-H1 | ||||
DT Family | Fatty Acid Transporter (FAT) Family ; | ||||
Tissue Specificity | Strongly expressed in heart and localizes tocardiac myocytes. Expressed at moderate levels in placenta,testis, and adrenal glands. Expressed at very low levels inkidney, bladder and uterus. | ||||
Function | This transporter mediates the transport of long chain fatty acids (LFCA) through plasma membrane. It is believed to be the major fatty acid protein transporter in the heart. | ||||
Endogenous Substrate(s) | Fatty acids | ||||
Variability Data of This Drug Transporter (DT) | |||||
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
(β) Post-translational Modification of This DT |
|||||
(γ) Transcriptional Regulation of This DT |
|||||
(δ) Epigenetic Regulation of This DT |
|||||
General Variability Data of This DT (VARIDT 1.0) |
|||||
(β) Disease-specific Protein Abundances of This DT |
|||||
(γ) Species- and Tissue-specific DT Abundances |
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.